Skip to main content

Precision Medicine Initiative Progress Update

The Precision Medicine Initiative (PMI) and the Translational Precision Medicine Complex (TPMC) are a top-priority research investment for the UM System and both projects seek to enable researchers and clinicians to collaborate using the most advanced technologies and data analysis tools. Together, these critical initiatives will support “bench-to-bedside” approach; accelerate the development of novel diagnostic tools and treatments; and allow for fast tracking of the application of proven medical strategies to clinical settings.

Upcoming Progress Report Events

There are no upcoming progress reports. Please check back, as new events will be posted as they are planned.

Past Progress Report Events

Bringing the Vision to Life (February 6, 2019)


Welcome and Introductions Mark McIntosh, UM System Vice President, Research and Economic Development and MU Vice Chancellor of Research, Graduates Studies and Economic Development
Building Design and Components Burns & McDonnell, Chief Architects of the TPMC
Overview (Planning Process, TPMC Operational Plans and Expectations, Innovation Space and Corporate Relationships) Elizabeth Loboa, Dean of the MU College of Engineering and MU Vice Chancellor for Strategic Partnerships
Research Working Group Reports  
Vascular Working Group Kerry McDonald, Interim Chair, Medical Pharmacology and Physiology
Cancer Working Group Jeffrey Bryan, Professor of Oncology, Department of Veterinary Medicine
Neurological Working Group David Schulz, Professor of Biological Sciences
Marketing Report Kamrhan Farwell, UM System Chief Marketing and Communications Officer
Finance Report Ryan Rapp, UM System Vice President for Finance and Chief Financial Officer and Rhonda Gibler, MU Vice Chancellor of Finance
Government Relations Report Dusty Schnieders, UM System Director of Government Relations
Philanthropy Update Tom Hiles, MU Vice Chancellor for University Advancement

Reviewed 2019-08-05